ORIGINAL RESEARCH
Accepted on 22 Apr 2025
Predictive Factors of Persistent Thrombocytopenia after Peptide Receptor Radioligand Therapy in Enteropancreatic Neuroendocrine Tumors
doi 10.3389/fendo.2025.1568243
- Frontiers in Endocrinology
- Cancer Endocrinology
- Research Topics
- Advances in Targeted Therapy and Biomarker Research for Endocrine-Related Cancers, Volume II
Advances in Targeted Therapy and Biomarker Research for Endocrine-Related Cancers, Volume II
943
Total downloads
3,083
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Published on 12 Feb 2025
A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report
doi 10.3389/fimmu.2025.1544604
- 707 views
MINI REVIEW
Published on 11 Feb 2025
CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies
doi 10.3389/fendo.2025.1517525
- 982 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.